What question did this study set out to answer?

To explore presymptomatic detection strategies and their importance in spinal muscular atrophy treatment.

November 1, 2025Revue NeurologiqueOpen Access

Presymptomatic detection of spinal muscular atrophy: Ongoing revolution for a devastating disorder

View Full Paper

Ask AI

Bookmark

Authors

Review shows benefits of newborn screening for spinal muscular atrophy, suggesting cost-effectiveness over traditional treatment.

To explore presymptomatic detection strategies and their importance in spinal muscular atrophy treatment.
Review of existing literature on spinal muscular atrophy and presymptomatic detection.
Assessment of newborn screening programs for spinal muscular atrophy.
Evaluation of ethical, economic, and political implications of early detection.
Newborn screening for spinal muscular atrophy demonstrates clear patient benefits.
Early treatment significantly improves patient outcomes compared to post-symptomatic treatment.
Cost-effectiveness studies support newborn screening as a dominant strategy for management.

V Laugel (2025) studied this question.

View Full Paper

Ask AI

Bookmark